Exact Mass: 317.952
Exact Mass Matches: 317.952
Found 106 metabolites which its exact mass value is equals to given mass value 317.952,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
8-O-4'-Diferulic acid
D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals
Tiludronate
Tiludronate is only found in individuals that have used or taken this drug. It is a bisphosphonate characterized by a (4-chlorophenylthio) group on the carbon atom of the basic P-C-P structure common to all bisphosphonates.The bisphosphonate group binds strongly to the bone mineral, hydroxyapatite. This explains the specific pharmacological action of these compounds on mineralized tissues, especially bone. In vitro studies indicate that tiludronate acts primarily on bone through a mechanism that involves inhibition of osteoclastic activity with a probable reduction in the enzymatic and transport processes that lead to resorption of the mineralized matrix. Bone resorption occurs following recruitment, activation, and polarization of osteoclasts. Tiludronate appears to inhibit osteoclasts by at least two mechanisms: disruption of the cytoskeletal ring structure, possibly by inhibition of protein-tyrosine-phosphatase, thus leading to detachment of osteoclasts from the bone surface and the inhibition of the osteoclastic proton pump. M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates
Mitotane
Mitotane is only found in individuals that have used or taken this drug. It is a derivative of the insecticide dichlorodiphenyldichloroethane that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression. [PubChem]Its biochemical mechanism of action is unknown, although data are available to suggest that the drug modifies the peripheral metabolism of steroids as well as directly suppressing the adrenal cortex. C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2355 - Anti-Adrenal L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents D000970 - Antineoplastic Agents
3,3',4,4'-Tetrachloroazobenzene
Environmental pollutant arising from the soil degradation of
3-Bromomethyl-2,3,6-trichloro-7-methyl-1,6-octadiene
4-Bromo-1,5-dichloro-2-chloroethenyl-1,5-dimethylcyclohexane
1-(1,2-Dichloroethyl)-4-bromo-5,5-dimethyl-6-chloro-1-cyclohexene
5-IODO-BENZO[B]THIOPHENE-2-CARBOXYLIC ACID METHYL ESTER
2-chloro-4-[(3-chloro-4-isocyanato-phenyl)methyl]-1-isocyanato-benzene
1H-Indene-1,3(2H)-dione, 2-[(3,5-dichloro-4-hydroxyphenyl)methylene]-
N-(2,6-DICHLORO-4-PYRIDYL)-N-[5-(METHYLTHIO)-4H-1,2,4-TRIAZOL-3-YL]UREA
4-(3-IODO-1H-PYRAZOL-4-YL)-2-(METHYLTHIO)PYRIMIDINE
2-(4-nitrophenoxy)-3-chloro-5-trifluoromethyl pyridine
1-Butanesulfonylchloride, 1,1,2,2,3,3,4,4,4-nonafluoro-
5-[amino(methyl)amino]-4-chloro-2-(3,5-dichlorophenyl)pyridazin-3-one
1-(5-Bromo-2-hydroxyphenyl)-3-phenyl-1,3-propanedione
Nickel(2+),hexaammine-, dibromide, (OC-6-11)- (9CI)
6-IODO-BENZO[B]THIOPHENE-2-CARBOXYLIC ACID METHYL ESTER
5-(2-(BROMOMETHYL)PHENYL)-1-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE
3-(4-bromophenyl)-5-(4-fluorophenyl)-1,2,4-oxadiazole
4-(5-Iodo-1H-pyrazol-4-yl)-2-(methylthio)pyrimidine
3-(4-Bromophenyl)-5-(2-fluorophenyl)-1,2,4-oxadiazole
3-(2-Bromophenyl)-5-(2-fluorophenyl)-1,2,4-oxadiazole
ethyl (2Z,4Z)-5-chloro-2-(chloromethyl)-5-(3-chlorophenyl)penta-2,4-dienoate
4-CHLORO-2-(2,4-DICHLOROPHENYL)-5-(1-METHYLHYDRAZINO)-2,3-DIHYDROPYRIDAZIN-3-ONE
2-BROMO-4,4,4-TRIFLUORO-3,3-DIHYDROXY-1-(2-THIENYL)BUTAN-1-ONE
3-Chloro-1-(3,4-dichlorophenyl)-4-(dimethylamino)pyrrole-2,5-dione
4-chloro-N-(3,4,5-trimethoxyphenyl)-5-dithiazolimine
Tiludronic Acid
M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates
